Ovarian Cyst Evaluation and Management

Initial Evaluation

• The American College of Radiology recommends transvaginal ultrasound as the first-line examination for suspected ovarian cysts, complemented by transabdominal ultrasound for large masses 1, 2
• Ultrasound allows classification of cysts as simple, complex, or solid, which directly determines management 2
• Color Doppler should be used to evaluate the vascularity of solid components 2, 3
• MRI with contrast becomes the exam of choice when ultrasound is indeterminate 1
• CT is not indicated for characterizing ovarian cysts due to its poor soft tissue discrimination 1

Tumor Markers

• The American College of Radiology states that serum CA-125 measurement should be performed before any surgery or chemotherapy, but is not recommended as a first-line diagnostic test in adult women 4
• CA-125 alone performs less well than ultrasound in distinguishing benign from malignant lesions 1
• CA-125 improves specificity only for lesions already suspected on ultrasound 1
• Other markers (CEA, CA19.9) should only be measured if CA-125 is not elevated 4
• CA-125 can be low in borderline and low-grade malignant tumors 1

Risk Stratification by Menopausal Status

Premenopausal Women

• Simple cysts ≤5 cm require no additional management as they are physiological with a malignancy risk <1% 4, 3
• Simple cysts >5 cm but <10 cm: ultrasound follow-up at 8-12 weeks, ideally during the proliferative phase 4, 3
• Hemorrhagic cysts ≤5 cm: no management necessary 4
• Endometriomas and dermoid cysts: optional follow-up at 8-12 weeks, then annual surveillance 4
• The risk of malignancy for unilocular cysts is only 0.5-0.6% 4

Postmenopausal Women

• Simple cysts ≤3 cm require no additional management 4
• Simple cysts >3 cm but <10 cm: at least one follow-up at 1 year showing stability or decrease, with annual surveillance up to 5 years if stable 4, 3
• Hemorrhagic cysts: additional evaluation by ultrasound specialist, gynecologic referral, or MRI 4
• Endometriomas and dermoid cysts: annual ultrasound surveillance due to the risk of malignant transformation 4
• In a prospective study, 53% of simple cysts completely disappeared, 28% remained constant 1

O-RADS Classification and Management

• The O-RADS system provides a standardized risk stratification that directly guides management 4, 3
• O-RADS 1-2 (risk <1%): No follow-up or surveillance only 4
• O-RADS 3 (risk 1-10%): Management by general gynecologist with consultation of an ultrasound specialist or MRI examination 4
• O-RADS 4 (risk 10-50%): Consultation with gynecologic oncology before removal or referral for management 4
• O-RADS 5 (risk 50-100%): Direct referral to a gynecologic oncologist 4

Absolute Surgical Indications

• Any cyst >10 cm requires surgical management, regardless of patient group 4, 5
• Complex cysts in postmenopausal women 4
• Symptomatic persistent cysts despite conservative management 5
• Increase in size or morphological change during follow-up 4
• Development of solid components, septations, or irregular walls 4

Absolute Contraindications

• Transvaginal aspiration is contraindicated for purely liquid cysts >5 cm in postmenopausal women 4
• Fine-needle aspiration for cytological examination of solid or mixed ovarian masses is contraindicated due to the risk of disseminating cancer cells 4, 5

Common Pitfalls to Avoid

• Do not operate prematurely on simple cysts <10 cm without an appropriate observation period—the risk of malignancy is extremely low 4
• Do not assume that all persistent cysts are pathological—many benign neoplasms can be safely followed with a malignancy risk <1% 4
• The risk of acute complications (torsion, rupture) in lesions with a benign appearance is only 0.2-0.4% 4, 3
• Do not neglect the possibility of functional cysts in premenopausal women, which usually resolve within 8-12 weeks 3
• Ensure adequate follow-up for cysts >5 cm as larger cysts can be more difficult to evaluate completely 3

Ultrasound Surveillance and Evaluation of Complex Ovarian Cysts ≤ 5 cm

Initial Management and Follow‑Up Timing

• In women with a complex ovarian cyst measuring about 5 cm, a repeat ultrasound is recommended 8–12 weeks after the initial scan (ideally during days 5–10 of the menstrual cycle, i.e., the proliferative phase) to determine whether the lesion has resolved, persisted, or acquired worrisome features; persistent or enlarging cysts, or those developing solid components, should be referred to a gynecologist. 6
• For premenopausal patients, cysts of this size are placed in a surveillance category rather than proceeding directly to surgical removal. 6

Ultrasound Assessment Criteria at Follow‑Up

• The follow‑up examination must evaluate:

Imaging Technique Recommendations

• Cysts approaching 5 cm should be examined with both transvaginal and transabdominal ultrasound windows, because larger lesions may not be fully visualized with a transvaginal approach alone. 6

Typical Benign Complex Cyst Subtypes and Follow‑Up Strategies

• Hemorrhagic (functional) cysts – characterized by a reticular pattern, retracting clot, concave margins, and lack of internal vascularity; these usually resolve spontaneously and are managed with an 8–12‑week repeat scan. 6
• Endometriomas – show homogeneous low‑level echoes with a “ground‑glass” appearance; an optional 8–12‑week scan is followed by annual surveillance if the lesion remains stable. 6
• Dermoid (mature cystic teratoma) cysts – display echogenic components with posterior acoustic shadowing; similarly, an optional 8–12‑week scan is followed by yearly monitoring when unchanged. 6